JEF catalysts
Catalysts and events linked to JEF, newest first.
JEF stock catalysts and risks
Latest published review: 2026-10-20
| Development | Transmission channel | Evidence | Condition to watch |
|---|---|---|---|
| Electra Therapeutics Sets Terms for $347M Nasdaq IPO 2026-09-20 · Up | ECM underwriting fee realization | Jefferies listed among offering participants in IPO syndicate. | Not recorded |
| Electra Therapeutics Sets Nasdaq IPO Terms to Raise Up to $347M 2026-09-20 · Up | ECM underwriting fee realization | Underwriter on up to $347M healthcare initial public offering | Not recorded |
Do these developments change your position?
Review JEF alongside your other holdings and identify which decision deserves attention first.
Review your initial audit before choosing ongoing portfolio scanning at $79/month.
DateCardAvg 5d
- 2026-09-20Electra Therapeutics Sets Nasdaq IPO Terms to Raise Up to $347MJEF
- 2026-09-20Electra Therapeutics Sets Terms for $347M Nasdaq IPOJEF
- 2026-09-20Electra Therapeutics Sets Nasdaq IPO Terms to Raise Up to $347METRA JEF
- 2026-09-20Electra Therapeutics Sets Terms for $347M Nasdaq IPOETRA JEF
See today's live cards
Public pages are published 24 hours after the product shows them. Desk shows every catalyst, event and causal reading as it happens, mapped to your holdings.